Schedule 13G ownership disclosure

EDESA BIOTECH INC

Common Stock, without par value · CUSIP: 27966L306

Event date: 2025-02-13

Filing-level shares
0.00
Percent of class
0%
  • Thomas A. Satterfield, Jr.

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014771
Form type
SCHEDULE 13G/A
Filer
Edesa Biotech, Inc.
CIK
CIK 1540159
Filed
Feb 18, 2025
Reporting period
Feb 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub